Drug Eluting Stent

Terumo is a well-known medical device company, and Ultimaster is a brand associated with their drug-eluting stent (DES) products. Drug-eluting stents are devices used in interventional cardiology to treat coronary artery disease.

the Boston Scientific Promus Elite is a coronary drug-eluting stent system. It is designed for use in patients undergoing percutaneous coronary intervention (PCI) procedures to treat coronary artery disease. Here are some key features and points related to the Boston Scientific Promus Elite coronary stent: Drug-Eluting Stent: The Promus Elite is a drug-eluting stent (DES), meaning it is coated with medication to help prevent the re-narrowing (restenosis) of the treated coronary artery. Drug Coating: The stent typically features a polymer coating containing an anti-proliferative drug. This drug is slowly released over time to inhibit the growth of tissue inside the stent, reducing the risk of restenosis. Cobalt Chromium Alloy: The stent is often made of a cobalt chromium alloy, known for its strength and flexibility. This material allows for a thin stent strut design, which can be beneficial in terms of deliverability and conformability. Delivery System: The stent is delivered to the target area using a catheter-based delivery system. The catheter is guided through the blood vessels to the site of the coronary artery lesion. Radiopaque Markers: Radiopaque markers on the stent aid in proper placement and visualization under X-ray guidance during the procedure.

Biosensors is a medical device company known for its innovations in interventional cardiology, particularly in the field of coronary stents. The BioMatrix platform includes a range of drug-eluting stents (DES) designed to be used in the treatment of coronary artery disease. Key features of the BioMatrix stent platform, which may extend to the NeoFlex model if it's a part of the series, may include: Drug-Eluting Stent: The stents in the BioMatrix platform are drug-eluting, meaning they are coated with a medication (such as an anti-restenotic drug) designed to inhibit the regrowth of tissue inside the treated blood vessel. Biodegradable Polymer: Some versions of the BioMatrix stent use a biodegradable polymer to deliver the drug to the target site. The polymer gradually dissolves over time, leaving only the metallic stent behind. Flexible Design: The stents are designed to be flexible, allowing for easier navigation and deployment in the coronary arteries. Thin-Strut Technology: Thin struts can contribute to improved deliverability and conformability of the stent to the vessel wall. Various Sizes: The BioMatrix stent platform typically offers stents in various sizes to accommodate different patient anatomies and lesion characteristics.